Patents by Inventor Adrien Nougarede

Adrien Nougarede has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • HYBRID htiRNA / NANOPARTICLE COMPLEX AND USE THEREOF FOR TREATING A DISEASE OF THE DIGESTIVE SYSTEM
    Publication number: 20230136944
    Abstract: A hybrid DNA/RNA molecule, or a complex thereof with at least one nanoparticle, may be used for the prevention or treatment of a disease, in particular a disease of the digestive system.
    Type: Application
    Filed: July 15, 2018
    Publication date: May 4, 2023
    Applicant: COMMISSARIAT A L'ENERGIE ATOMIQUE ET AUX ENERGIES ALTERNATIVES
    Inventors: Fabrice NAVARRO Y GARCIA, Dorothee JARY, Adrien NOUGAREDE
  • Inhibitors of the Interaction BCL-2 L10 / IP3 Receptors
    Publication number: 20190030126
    Abstract: The present invention relates to a competitive inhibitor of the binding of the protein Bcl-2 L10 to the ligand binding domain of at least one of the IP3R receptors, for its use in the treatment of cancers, the cells of which express the protein Bcl-2 L10.
    Type: Application
    Filed: March 8, 2017
    Publication date: January 31, 2019
    Applicants: Universite Claude Bernard - Lyon 1, Centre Leon Berard, Centre National de la Recherche Scientifique (CNRS ), Institut National de la Sante et de la Recherche M edicale (INSERM)
    Inventors: Adrien Nougarede, Ruth Rimokh, Germain Gillet, Nikolay Georgiev